Fazel Darbandi, Siavash
Nelson, Andrew D.
Pai, Emily Ling-lin
Bender, Kevin J.
Rubenstein, John L. R.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (NINDS R01 NS34661)
National Institutes of Health (R01 NS099099, NIH R01 MH125978, NIH F32 MH125536)
Simons Foundation (630332)
Article History
Received: 6 August 2021
Accepted: 25 January 2022
First Online: 5 February 2022
Declarations
:
: All procedures and animal care were approved and performed in accordance with the University of California San Francisco Laboratory Animal Research Center (LARC) guidelines.
: All contributing authors have read and agreed to submit this manuscript for publication.
: J.L.R.R. is the cofounder, stockholder, and currently on the scientific board of <i>Neurona</i>, a company studying the potential therapeutic use of interneuron transplantation. The other authors declare that they have no competing interests.